This meeting will focus on the latest developments in oligonucleotide discovery and delivery. Presentations will include information on mechanisms for the targeted delivery of oligonucleotides, chemistry, and data of compounds in clinical development. Representatives from large pharma and biotech companies will discuss the emerging therapeutic applications of oligonucleotides, featuring case studies as well as information on chemistry, manufacturing and controls and regulation.
